Singapore markets closed

Tenax Therapeutics, Inc. (TENX)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
3.8400-0.0200 (-0.52%)
At close: 04:00PM EDT
3.7100 -0.13 (-3.39%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
5,158
3,229
5,377
25,147
4,561
Selling general and administrative
6,552
5,005
5,675
7,581
5,307
Total operating expenses
11,710
8,234
11,053
32,728
9,868
Operating income or loss
-11,710
-8,234
-11,053
-32,728
-9,868
Interest expense
4.443
23.967
4.443
0.949
1.627
Total other income/expenses net
4.603
547.235
9.191
254.832
18.166
Income before tax
-11,710
-7,711
-11,048
-32,474
-9,851
Income from continuing operations
-11,710
-7,711
-11,048
-32,474
-9,851
Net income
-11,710
-7,711
-11,048
-32,474
-9,851
Net income available to common shareholders
-11,710
-7,711
-11,048
-32,474
-9,851
Basic EPS
-88.80
-
-600.71
-2.52k
-1.52k
Diluted EPS
-88.80
-
-600.71
-2.52k
-1.52k
Basic average shares
180.138
-
18.391
12.86
6.478
Diluted average shares
180.138
-
18.391
12.86
6.478